Trends in thrombolytic treatment and outcomes of acute pulmonary embolism in Germany

Short summary

Systemic thrombolysis for acute pulmonary embolism (PE) increased slightly (3.1% to 4.4%) in Germany from 2005-2015, yet remained underutilized in hemodynamically unstable patients (23.1%). This treatment was associated with reduced in-hospital mortality for PE patients with shock (OR 0.42) and those undergoing CPR (OR 0.92).

AI-generated from the title and abstract; the full text is not read.